MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut

reuters.com/business/healthcare-pharmaceuticals/maplight-therapeutics-valued-787-million-shares-jump-nasdaq-debut-2025-10-27

This story appeared on reuters.com, 2025-10-27 15:55:02.925000.
The Entire Business World on a Single Page. Free to Use →